C
Genmab A/S GMAB
$24.65 $0.230.94% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 3.38B 3.23B 3.12B 2.89B 2.76B
Total Other Revenue -- -- -- -- --
Total Revenue 3.38B 3.23B 3.12B 2.89B 2.76B
Cost of Revenue 187.39M 158.39M 143.39M 113.42M 84.73M
Gross Profit 3.19B 3.07B 2.98B 2.77B 2.67B
SG&A Expenses 575.96M 560.96M 559.96M 516.30M 514.43M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.19B 2.15B 2.11B 1.94B 1.88B
Operating Income 1.18B 1.09B 1.01B 942.03M 875.86M
Income Before Tax 1.44B 1.32B 1.32B 954.68M 1.09B
Income Tax Expenses 168.02M 185.02M 193.02M 271.64M 287.55M
Earnings from Continuing Operations 1.27K 1.13K 1.13K 683.04 803.76
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 1.27B 1.13B 1.13B 683.04M 803.76M
EBIT 1.18B 1.09B 1.01B 942.03M 875.86M
EBITDA 1.23B 1.13B 1.06B 979.90M 910.40M
EPS Basic 17.47 15.18 15.17 8.07 9.84
Normalized Basic EPS 11.73 10.79 10.75 6.73 8.10
EPS Diluted 17.35 15.06 15.04 8.01 9.76
Normalized Diluted EPS 11.64 10.70 10.66 6.68 8.04
Average Basic Shares Outstanding 628.60M 631.28M 639.95M 641.76M 643.57M
Average Diluted Shares Outstanding 631.31M 634.18M 644.45M 646.36M 648.32M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --